Skip to main
AUPH
AUPH logo

Aurinia Pharmaceuticals (AUPH) Earnings Dates & Reports

Aurinia Pharmaceuticals (AUPH) Most Recent Earnings

Report DateJul 31, 2025
Period EndingQ2 2025
Est. EPS$0.16
Actual EPS$0.16
EarningsMeet

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aurinia Pharmaceuticals (AUPH) Earnings per Share (EPS) History

Signup for full access
Browse free

Aurinia Pharmaceuticals (AUPH) Latest Earnings

The value each AUPH share was expected to gain vs. the value each share gained.

Aurinia Pharmaceuticals (AUPH) reported its most recent earnings on Jul 31, 2025 for Q2 2025, posting earnings per share (EPS) of $0.16. This exceeded analysts' expectations of $0.16 by 0.00%, marking a Meet.

For comparison, Aurinia Pharmaceuticals reported EPS of $0.01 in the same quarter last year.

The company is expected to announce its next earnings report on 11/06/2025, with analysts projecting an EPS of $0.16.

Aurinia Pharmaceuticals (AUPH) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 6, 2025
$0.16Next earnings call Nov. 6, 2025
Q2 2025Jul 31, 2025
$0.16$0.160.00%
DeckReportListen
Q1 2025May 12, 2025
$0.10$0.16+60.00%
Q4 2024Feb 27, 2025
-$0.02$0.01-150.00%
Q3 2024Nov 7, 2024
$0.01$0.10+900.00%
View all

Aurinia Pharmaceuticals (AUPH) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Aurinia Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 31, 2025
May 12, 2025
Feb 27, 2025
Nov 7, 2024

Aurinia Pharmaceuticals (AUPH) Earnings FAQs

Aurinia Pharmaceuticals (AUPH) last reported earnings on Jul 31, 2025 for Q2 2025, posting an EPS of $0.16, which Meet the estimate of $0.16 by 0.00%.

For Q2 2025, Aurinia Pharmaceuticals (AUPH) reported an EPS of $0.16, missing analysts' estimate of $0.16 by 0.00%.

For Q2 2025, Aurinia Pharmaceuticals (AUPH) Meet expectations with an actual EPS of $0.16 vs. an estimated EPS of $0.16.

Following the last earnings report on Jul 31, 2025, Aurinia Pharmaceuticals (AUPH)'s stock price moved — from — to —.

The next Aurinia Pharmaceuticals (AUPH) earnings call is scheduled for Nov. 6, 2025, where executives will discuss financial results and outlook.

Aurinia Pharmaceuticals (AUPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.